Search

Lymphomas from A to Z

Nineteen countries from 3 continents were represented during the EHA-SWG Scientific Meeting on Rare Lymphomas on March 10-12, 2017 in Barcelona, Spain.

Read more

The new EU clinical trials map is online

A new clinical trial map was launched by EMA as part of the Clinical Trials Information System (CTIS) on March 3.

Read more

Trial membership

Are you interested in connecting with EHA and our vibrant community, but you're not yet ready to apply for membership?

By becoming an EHA guest, you can enjoy 60 days of free access to:

The European Hematology Curriculum
Select courses on EHA Campus
You'll…

Read more

ATMPs and CAR-T: the uptake challenge

Advanced therapy medicinal products (ATMPs) are a game changer for improving the life of patients with severe to life-threatening diseases. In hematology, for instance, CAR T cell therapy has shown promising results in tackling different blood cancers.

Read more

Improved survival for adult Acute Lymphoblastic Leukemia (ALL) patients

Historical survival for patients 18-45 years with ALL is approximately 40 %. However the event free survival for ALL patients 18-45 years has improved to 73% following implementation of the NOPHO ALL2008 protocol in July 2008.

Read more

Meet Fabienne Lucas, our January Volunteer of the Month

EHA is a Public Benefit Organization under Dutch law.

Read more